Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo D Müller

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
Cell Metabolism|August 17, 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applicationsJonathan E Campbell, Timo D Müller, Brian Finan, et al.
Molecular Metabolism|November 27, 2019
Corrigendum to "Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice" [Molecular Metabolism 23 (2019) 75-81]Sigrid Jall, Brian Finan, Gustav Collden, et al.
Plos One|September 13, 2012
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptidesRudolf L Riepl, Rainald Fischer, Hubert Hautmann, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Cell|July 26, 2024
Transforming obesity: The advancement of multi-receptor drugsChristine M Kusminski, Diego Perez-Tilve, Timo D Müller, et al.
Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.
Molecular Metabolism|March 24, 2019
Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in miceSigrid Jall, Brian Finan, Gustav Collden, et al.
Frontiers in Nutrition|May 20, 2015
The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin ReceptorKatrin Fischer, Brian Finan, Christoffer Clemmensen, et al.
Frontiers in Endocrinology|March 18, 2022
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and DiabetesQiming Tan, Seun E Akindehin, Camila E Orsso, et al.
BMC Research Notes|December 18, 2014
The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonistAnne Müller, Brinja Leinweber, Jana Fischer, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
Cell Metabolism|August 17, 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applicationsJonathan E Campbell, Timo D Müller, Brian Finan, et al.
Molecular Metabolism|November 27, 2019
Corrigendum to "Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice" [Molecular Metabolism 23 (2019) 75-81]Sigrid Jall, Brian Finan, Gustav Collden, et al.
Plos One|September 13, 2012
Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptidesRudolf L Riepl, Rainald Fischer, Hubert Hautmann, et al.
Cell Metabolism|July 14, 2016
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityMatthias H Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Cell|July 26, 2024
Transforming obesity: The advancement of multi-receptor drugsChristine M Kusminski, Diego Perez-Tilve, Timo D Müller, et al.
Diabetologia|July 23, 2017
GLP-1/glucagon receptor co-agonism for treatment of obesityMiguel A Sánchez-Garrido, Sara J Brandt, Christoffer Clemmensen, et al.
Molecular Metabolism|March 24, 2019
Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in miceSigrid Jall, Brian Finan, Gustav Collden, et al.
Frontiers in Nutrition|May 20, 2015
The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin ReceptorKatrin Fischer, Brian Finan, Christoffer Clemmensen, et al.
Frontiers in Endocrinology|March 18, 2022
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and DiabetesQiming Tan, Seun E Akindehin, Camila E Orsso, et al.
BMC Research Notes|December 18, 2014
The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonistAnne Müller, Brinja Leinweber, Jana Fischer, et al.
Pageof 19